The Pharmacology of Opioids

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-0-387-72527-7_15
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcome of long-term heroin-assisted treatment offered to chronic, treatment-resistant heroin addicts in the Netherlands.

  2010cited by this paper
• Hormones, brain, and behavior

  2009cited by this paper
• Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain.

  2009cited by this paper
• Evidence that morphine is metabolized to hydromorphone but not to oxymorphone.

  2008cited by this paper
• Opioids and the control of respiration.

  2008cited by this paper
• Pain and Chemical Dependency

  2008cited by this paper
• ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.

  2008cited by this paper
• Differential Activation and Trafficking of μ-Opioid Receptors in Brain Slices

  2008cited by this paper
• Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment

  2007cited by this paper
• Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.

  2007cited by this paper
• The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.

  2007cited by this paper
• Oxycodone: a pharmacological and clinical review

  2007cited by this paper
• Development of opioid formulations with limited diversion and abuse potential.

  2006cited by this paper
• Role of cAMP Response Element-Binding Protein in the Rat Locus Ceruleus: Regulation of Neuronal Activity and Opiate Withdrawal Behaviors

  2006cited by this paper
• Pharmacokinetic Drug Interactions Between Opioid Agonist Therapy and Antiretroviral Medications: Implications and Management for Clinical Practice

  2006cited by this paper
• Abuse of prescription drugs and the risk of addiction.

  2006cited by this paper
• Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.

  2006cited by this paper
• Pharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose‐Escalation Trials

  2006cited by this paper
• Are mu-opioid receptor polymorphisms important for clinical opioid therapy?

  2005cited by this paper
• Medications development: successes and challenges.

  2005cited by this paper
• Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.

  2005cited by this paper
• Impact of methadone treatment on cardiac repolarization and conduction in opioid users.

  2005cited by this paper
• The pharmacokinetics of oxycodone.

  2005cited by this paper
• Regulation of Gene Expression by Chronic Morphine and Morphine Withdrawal in the Locus Ceruleus and Ventral Tegmental Area

  2005cited by this paper
• Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden

  2005cited by this paper
• Pharmacogenetics and Human Molecular Genetics of Opiate and Cocaine Addictions and Their Treatments

  2005cited by this paper
• Opioids: cellular mechanisms of tolerance and physical dependence.

  2005cited by this paper
• Effects of Methadone on QT‐Interval Dispersion

  2005cited by this paper
• Polymorphism of &mgr;-Opioid Receptor Gene (OPRM1:c.118A>G) Does Not Protect Against Opioid-induced Respiratory Depression despite Reduced Analgesic Response

  2005cited by this paper
• Pharmacokinetics of Methadone

  2005cited by this paper
• Opioid use in the elderly

  2005cited by this paper
• Meperidine Is Alive and Well in the New Millennium: Evaluation of Meperidine Usage Patterns and Frequency of Adverse Drug Reactions

  2004cited by this paper
• Mu opiate receptor subtypes.

  2004cited by this paper
• Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats

  2004cited by this paper
• Comparison of renal excretion of pethidine (meperidine) and its metabolites in old and young patients

  2004cited by this paper
• Pharmacological Treatments for Persistent Non-Malignant Pain in Older Persons

  2004cited by this paper
• Buprenorphine: a primer for emergency physicians.

  2004cited by this paper
• Multiple opiate receptors: déjà vu all over again.

  2004cited by this paper
• Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden

  2004cited by this paper
• Simultaneous Measurement and Integrated Analysis of Analgesia and Respiration after an Intravenous Morphine Infusion

  2004cited by this paper
• Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone

  2004cited by this paper
• Methadone--metabolism, pharmacokinetics and interactions.

  2004cited by this paper
• Influence of Age on the Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Fentanyl Citrate

  2004cited by this paper
• Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment.

  2004cited by this paper
• Meperidine Suppresses the Excitability of Spinal Dorsal Horn Neurons

  2004cited by this paper
• Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.

  2004cited by this paper
• Comparative disposition of pethidine and norpethidine in old and young patients

  2004cited by this paper
• Functional Inhibition by Methadone of N-Methyl-d-Aspartate Receptors Expressed in Xenopus Oocytes: Stereospecific and Subunit Effects

  2004cited by this paper
• Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy

  2003cited by this paper
• Postoperative Morphine Consumption in the Elderly Patient

  2003cited by this paper
• A study of anesthetic drug utilization in different age groups.

  2003cited by this paper
• Analgesic effects of morphine and morphine‐6‐glucuronide in a transcutaneous electrical pain model in healthy volunteers

  2003cited by this paper
• Demographics, Assessment and Management of Pain in the Elderly

  2003cited by this paper
• Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers

  2003cited by this paper
• Response Surface Modeling of Remifentanil–Propofol Interaction on Cardiorespiratory Control and Bispectral Index

  2003cited by this paper
• Suppressed Prolactin Response to Dynorphin A1–13 in Methadone-Maintained Versus Control Subjects

  2003cited by this paper
• The impact of methadone induction on cardiac conduction in opiate users.

  2003cited by this paper
• Side effects of opioids during short‐term administration: Effect of age, gender, and race

  2003cited by this paper
• Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X.

  2003cited by this paper
• Age‐related differences in endogenous pain modulation: a comparison of diffuse noxious inhibitory controls in healthy older and younger adults

  2003cited by this paper
• Respiratory and miotic effects of morphine in healthy volunteers when P‐glycoprotein is blocked by quinidine

  2003cited by this paper
• QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone.

  2003cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Interactions of the narcotic l-α-acetylmethadol with human cardiac K+ channels

  2003cited by this paper
• Reduction and Lumping of Physiologically Based Pharmacokinetic Models: Prediction of the Disposition of Fentanyl and Pethidine in Humans by Successively Simplified Models

  2003cited by this paper
• Acute and Chronic Pain

  2003cited by this paper
• Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.

  2003cited by this paper
• QTc interval prolongation associated with intravenous methadone

  2003cited by this paper
• Input Characteristics and Bioavailability after Administration of Immediate and a New Extended-release Formulation of Hydromorphone in Healthy Volunteers

  2002cited by this paper
• μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization

  2002cited by this paper
• Paroxetine Increases Steady-State Concentrations of (R)-Methadone in CYP2D6 Extensive but Not Poor Metabolizers

  2002cited by this paper
• Pharmacokinetic modeling to predict morphine and morphine‐6‐glucuronide plasma concentrations in healthy young volunteers

  2002cited by this paper
• History and current status of opioid maintenance treatments: blending conference session.

  2002cited by this paper
• Meperidine: A Critical Review

  2002cited by this paper
• Neuropsychopharmacology : The Fifth Generation of Progress

  2002cited by this paper
• Interindividual Variability of the Clinical Pharmacokinetics of Methadone

  2002cited by this paper
• Anatomical and functional correlation of the endomorphins with mu opioid receptor splice variants

  2002cited by this paper
• Pharmacotherapy of addictions

  2002cited by this paper
• Clinical Pharmacology of Opioids for Pain

  2002cited by this paper
• Relationships between Endocrine Functions and Substance Abuse Syndromes

  2002cited by this paper
• Postoperative Titration of Intravenous Morphine in the Elderly Patient

  2002cited by this paper
• Torsade de Pointes Associated with Very-High-Dose Methadone

  2002cited by this paper
• The Transfer Half-life of Morphine-6-glucuronide from Plasma to Effect Site Assessed by Pupil Size Measurement in Healthy Volunteers

  2001cited by this paper
• Age-associated differences in responses to noxious stimuli.

  2001cited by this paper
• Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats

  2001cited by this paper
• Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations

  2001cited by this paper
• Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.

  2001cited by this paper
• Altered HPA Axis Responsivity to Metyrapone Testing in Methadone Maintained Former Heroin Addicts with Ongoing Cocaine Addiction

  2001cited by this paper
• Hydromorphone: pharmacology and clinical applications in cancer patients

  2001cited by this paper
• Pain Management in Older Adults: Prevention and Treatment

  2001cited by this paper
• Morphine-6-Glucuronide

  2001cited by this paper
• The epidemiology of pain in elderly people.

  2001cited by this paper
• Methadone maintenance in primary care: a randomized controlled trial.

  2001cited by this paper
• Selective postoperative inhibition of gastrointestinal opioid receptors.

  2001cited by this paper
• The Use of an Anesthesia Information Management System for Prediction of Antiemetic Rescue Treatment at the Postanesthesia Care Unit

  2001cited by this paper
• Age is not an impediment to effective use of patient-controlled analgesia by surgical patients.

  2000cited by this paper
• Methadone medical maintenance (MMM): treating chronic opioid dependence in private medical practice--a summary report (1983-1998).

  2000cited by this paper
• Age‐related differences in the time course of capsaicin‐induced hyperalgesia

  2000cited by this paper
• Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers

  2000cited by this paper
• Effect of pre-emptive hydromorphone administration on postoperative pain relief--a randomized controlled trial.

  2000cited by this paper

• Management of Acute Postoperative Pain in the Geriatric Patient

  2020cites this paper
• Perinatal Opioid Use

  2019cites this paper
• Nanomaterials for the sensing of narcotics: Challenges and opportunities

  2018cites this paper
• Sufentanil sublingual tablet 30 mcg for moderate-to-severe acute pain in the emergency department

  2017cites this paper
• Sufentanil Sublingual Tablet System for the Management of Postoperative Pain after Knee or Hip Arthroplasty: A Randomized, Placebo-controlled Study

  2015cites this paper
• Anesthesia for Urological Surgery in the Elderly Patient

  2014cites this paper
• “Killing Two Birds with One Stone”: Alcohol Use Reduction Interventions with Potential Efficacy at Enhancing Self-control

  2014cites this paper
• Optimizing an Opioid for PCA Delivery: The Clinical Importance of CST ½ and t ½ke0

  2013cites this paper
• Pain management in the ICU.

  2012cites this paper
• Acute Postoperative Pain Management in Elderly Patients

  2011cites this paper
• Other drugs acting on nervous system associated with QT-interval prolongation.

  2010cites this paper
• Polypharmacy and perioperative medications in the elderly.

  2009cites this paper
• Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network.

  2009cites this paper
• Beta-endorphin and drug-induced reward and reinforcement.

  2008cites this paper
• Meta-Analysis of Depressive Symptoms in Dual-Diagnosis Schizophrenia

  2007cites this paper
• Endogenous Opioid Blockade and Impulsive Responding in Alcoholics and Healthy Controls

  2007cites this paper
• Reduced alcohol consumption in mice lacking preprodynorphin.

  2006cites this paper